The Maharashtra government’s city planning body, the City and Industrial Development Corporation (CIDCO), is working on building a 2,000-bed COVID-19 treatment jumbo centre at Kanjurmarg, Mumbai in Maharashtra.
The proposed centre will be set up at the old Crompton Greaves factory land and have 1,400 oxygenated, 200 ICU and 400 non-oxygenated beds for the patients.
Apart from this, CIDCO is also building an 800-bed COVID centre at the Cotton Corporation of India’s warehouse in Navi Mumbai’s Kalamboli area with 690 oxygenated and 110 ICU beds.
So far, all the treatment centres in Mumbai have been constructed by the Municipal Corporation of Greater Mumbai (MCGM) and the Mumbai Metropolitan Region Development Authority (MMRDA).
The new centre is part of additional three new large facilities that will be built in the next few weeks. CIDCO has already floated tenders for the proposed centre in Kanjurmarg.
The proposed centre will be set up at the old Crompton Greaves factory land and have 1,400 oxygenated, 200 ICU and 400 non-oxygenated beds for the patients.
Apart from this, CIDCO is also building an 800-bed COVID centre at the Cotton Corporation of India’s warehouse in Navi Mumbai’s Kalamboli area with 690 oxygenated and 110 ICU beds.
So far, all the treatment centres in Mumbai have been constructed by the Municipal Corporation of Greater Mumbai (MCGM) and the Mumbai Metropolitan Region Development Authority (MMRDA).
The new centre is part of additional three new large facilities that will be built in the next few weeks. CIDCO has already floated tenders for the proposed centre in Kanjurmarg.
